Virtu Financial LLC Impel Pharmaceuticals Inc Transaction History

Virtu Financial LLC

  • $1.31 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.31 - $1.75 $4,994 - $28,196
16,112 New
16,112 $7,000
Q4 2021

Feb 17, 2022
SELL
$8.33 - $12.14 $94,803 - $138,165
-11,381 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$8.38 - $26.13 $95,372 - $297,385
11,381 New
11,381 $139,000

Others Institutions Holding IMPL

# of Institutions
1
Shares Held
14.4K
Call Options Held
0
Put Options Held
0
View Full List

About IMPEL PHARMACEUTICALS INC

IMPL Quotes by TradingView
  • Ticker IMPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,738,800
  • Market Cap $475K
  • Description
  • Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The c...
More about IMPL
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email